Home / Products / Others / 849217-68-1


Cat.No.ABP000796 Chemical NameCabozantinib/XL184 MolFormulaC28H24FN3O5 MolWeight501.5057 Purity 98%

Chemical Name : Cabozantinib/XL184

CAS : 849217-68-1

Synonyms: N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide

Storage:at -20℃ 2 years


GSK256066 is an exceptionally high affinity and selective PDE4 inhibitor with an IC50 of 3.2 pM for PDE4B. GSK256066 suppressed tumor necrosis factor α production by lipopolysaccharide (LPS)-stimulated human peripheral blood monocytes with 0.01 nM IC50 (compared with IC50 values of 5, 22, and 389 nM for roflumilast, tofimilast, and cilomilast, respectively) and by LPS-stimulated whole blood with 126 pM IC50. GSK256066 also inhibited LPS-induced increases in exhaled nitric oxide (ED50=35 µg/kg). In addition, GSK256066 prevented pulmonary eosinophilia in rats exposed to ovalbumin (ED50=0.4 μg/kg). In ferrets, inhaled GSK256066 inhibited LPS-induced pulmonary neutrophilia (ED50=18 μg/kg) and no emetic episodes were observed. [1][2]


[1] Nials AT et al. J Pharmacol Exp Ther. 2011 Apr; 337(1):137-44.

[2] Singh D et al. Respir Res. 2010 Mar 1; 11:26.